Avantor (AVTR) Total Current Liabilities (2018 - 2026)
Avantor's (AVTR) quarterly Total Current Liabilities came in at $1.4 billion in Q1 2026, down 32.79% year-on-year from $2.0 billion in Q1 2025, and down 0.84% quarter-over-quarter from $1.4 billion in Q4 2025.
Avantor (AVTR) Total Current Liabilities (2018 - 2026) Analysis & Trends
Avantor's Total Current Liabilities history runs 9 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 32.79% year-over-year to $1.4 billion in Q1 2026; TTM through Mar 2026 was $1.4 billion, a 32.79% decrease from a year earlier, with the FY2025 full-year figure at $1.4 billion, down 31.31% from the prior year.
- Total Current Liabilities retreated to $1.4 billion in Q1 2026 per AVTR's latest filing, from $1.4 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $2.6 billion in Q2 2025 and bottomed at $1.4 billion in Q1 2026.
- The 5-year median for Total Current Liabilities is $1.6 billion (2023), against an average of $1.6 billion.
- Across the five-year window, Total Current Liabilities jumped 75.86% in 2025 and slumped 32.79% in 2026, its largest moves.
- Year by year, Total Current Liabilities stood at $1.7 billion in 2022, then dropped by 10.76% to $1.5 billion in 2023, then surged by 35.61% to $2.0 billion in 2024, then slumped by 31.31% to $1.4 billion in 2025, then decreased by 0.84% to $1.4 billion in 2026.
- Per Business Quant, the three latest AVTR Total Current Liabilities figures stand at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Avantor | 7.67 Bn | 7.39 Bn | 500.70 Mn | 1.37 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 1.38 Bn |
| Sep 30, 2025 | 1.52 Bn |
| Jun 30, 2025 | 2.58 Bn |
| Mar 31, 2025 | 2.03 Bn |
| Dec 31, 2024 | 2.01 Bn |
| Sep 30, 2024 | 1.63 Bn |
| Jun 30, 2024 | 1.46 Bn |
| Mar 31, 2024 | 1.44 Bn |
| Dec 31, 2023 | 1.48 Bn |
| Sep 30, 2023 | 1.49 Bn |
| Jun 30, 2023 | 1.55 Bn |
| Mar 31, 2023 | 1.67 Bn |
| Dec 31, 2022 | 1.66 Bn |
| Sep 30, 2022 | 1.55 Bn |
| Jun 30, 2022 | 1.57 Bn |
| Mar 31, 2022 | 1.45 Bn |
| Dec 31, 2021 | 1.45 Bn |
| Sep 30, 2021 | 1.32 Bn |
| Jun 30, 2021 | 1.38 Bn |